Repligen Corp. (RGEN)
176.93
-1.78
(-1.00%)
USD |
NASDAQ |
Oct 23, 16:00
176.66
-0.27
(-0.15%)
After-Hours: 20:00
Repligen Price : 176.93 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 178.30 | 179.54 | 174.90 | 176.93 | 1.066M |
| Oct 22, 2026 | 179.45 | 185.02 | 175.96 | 178.71 | 1.272M |
| Oct 21, 2026 | 174.37 | 183.49 | 172.00 | 180.01 | 903860.0 |
| Oct 20, 2026 | 176.50 | 180.67 | 174.37 | 178.88 | 877750.0 |
| Oct 19, 2026 | 177.82 | 178.66 | 174.26 | 176.43 | 769102.0 |
| Oct 16, 2026 | 183.81 | 186.00 | 172.39 | 175.42 | 1.213M |
| Oct 15, 2026 | 178.28 | 185.99 | 177.49 | 184.17 | 1.043M |
| Oct 14, 2026 | 175.42 | 181.07 | 175.39 | 178.20 | 1.217M |
| Oct 13, 2026 | 172.51 | 177.96 | 169.73 | 175.42 | 1.259M |
| Oct 12, 2026 | 171.73 | 173.82 | 169.90 | 172.51 | 899606.0 |
| Oct 09, 2026 | 164.21 | 174.82 | 164.21 | 173.88 | 1.340M |
| Oct 08, 2026 | 164.00 | 164.65 | 157.44 | 163.84 | 1.227M |
| Oct 07, 2026 | 174.75 | 175.04 | 165.99 | 167.22 | 2.630M |
| Oct 06, 2026 | 191.90 | 194.36 | 174.36 | 174.86 | 1.705M |
| Oct 05, 2026 | 178.75 | 191.26 | 178.61 | 189.50 | 1.614M |
| Oct 02, 2026 | 179.32 | 186.52 | 178.00 | 181.70 | 1.460M |
| Oct 01, 2026 | 194.00 | 194.00 | 177.12 | 177.23 | 1.946M |
| Sep 30, 2026 | 193.09 | 195.61 | 190.96 | 192.23 | 730435.0 |
| Sep 29, 2026 | 196.00 | 196.65 | 190.98 | 194.57 | 1.139M |
| Sep 28, 2026 | 187.25 | 198.87 | 187.11 | 194.09 | 1.567M |
| Sep 25, 2026 | 189.92 | 191.51 | 186.90 | 189.68 | 1.502M |
| Sep 24, 2026 | 184.10 | 192.49 | 183.75 | 190.65 | 1.603M |
| Sep 23, 2026 | 186.38 | 188.94 | 181.71 | 184.53 | 934768.0 |
| Sep 22, 2026 | 180.72 | 188.20 | 180.00 | 186.75 | 1.160M |
| Sep 21, 2026 | 176.89 | 182.25 | 176.22 | 180.71 | 857649.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 21.42 |
| Precigen, Inc. | 6.19 |
| Liquidia Corp. | 42.65 |
| Harmony Biosciences Holdings, Inc. | 36.13 |
| Agilent Technologies, Inc. | 173.07 |
Price Related Metrics
| PE Ratio | 241.15 |
| PS Ratio | 12.76 |
| Price to Book Value | 4.727 |
| Price to Free Cash Flow | 90.95 |
| Earnings Yield | 0.41% |
| Market Cap | 9.984B |
| Operating PE Ratio | 141.25 |
| Normalized PE Ratio | 216.77 |